Compare GKOS & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | HOMB |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.8B |
| IPO Year | 2015 | 2006 |
| Metric | GKOS | HOMB |
|---|---|---|
| Price | $120.85 | $28.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $130.93 | $32.60 |
| AVG Volume (30 Days) | 749.4K | ★ 1.2M |
| Earning Date | 02-17-2026 | 01-14-2026 |
| Dividend Yield | N/A | ★ 2.96% |
| EPS Growth | N/A | ★ 19.80 |
| EPS | N/A | ★ 2.41 |
| Revenue | $469,820,000.00 | ★ $1,069,964,000.00 |
| Revenue This Year | $31.33 | $7.29 |
| Revenue Next Year | $24.01 | $4.18 |
| P/E Ratio | ★ N/A | $11.77 |
| Revenue Growth | ★ 30.38 | 10.42 |
| 52 Week Low | $73.16 | $24.22 |
| 52 Week High | $163.71 | $31.27 |
| Indicator | GKOS | HOMB |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 49.10 |
| Support Level | $93.96 | $28.46 |
| Resistance Level | $130.23 | $29.79 |
| Average True Range (ATR) | 5.30 | 0.72 |
| MACD | 0.77 | 0.04 |
| Stochastic Oscillator | 75.23 | 36.87 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.